Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Acquisitions (2016 - 2023)

Avanos Medical (AVNS) has disclosed Acquisitions for 6 consecutive years, with $2.1 million as the latest value for Q4 2023.

  • Quarterly Acquisitions changed N/A to $2.1 million in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $49.6 million through Dec 2023, down 57.28% year-over-year, with the annual reading at $28.0 million for FY2025, N/A changed from the prior year.
  • Acquisitions hit $2.1 million in Q4 2023 for Avanos Medical, down from $45.0 million in the prior quarter.
  • In the past five years, Acquisitions ranged from a high of $116.7 million in Q1 2022 to a low of -$4.0 million in Q4 2020.
  • Historically, Acquisitions has averaged $27.0 million across 4 years, with a median of $3.2 million in 2020.
  • Biggest five-year swings in Acquisitions: plummeted 92.08% in 2020 and later surged 7600.0% in 2023.
  • Year by year, Acquisitions stood at $50.5 million in 2019, then plummeted by 107.92% to -$4.0 million in 2020, then soared by 85.0% to -$600000.0 in 2022, then soared by 450.0% to $2.1 million in 2023.
  • Business Quant data shows Acquisitions for AVNS at $2.1 million in Q4 2023, $45.0 million in Q3 2023, and $2.5 million in Q2 2023.